<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Biology</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/43ABBACA-31B2-4B9A-B195-8804ED853679"><gtr:id>43ABBACA-31B2-4B9A-B195-8804ED853679</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:otherNames>George</gtr:otherNames><gtr:surname>Sturmey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4ED6B52C-AA1A-483D-9C6C-9BB220E22BD4"><gtr:id>4ED6B52C-AA1A-483D-9C6C-9BB220E22BD4</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Leese</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D691F44B-AB3E-494A-B0A8-AE9E25F69131"><gtr:id>D691F44B-AB3E-494A-B0A8-AE9E25F69131</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Colin</gtr:otherNames><gtr:surname>Bielby</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/33FCF120-94EE-4877-98AE-0184413E1D4A"><gtr:id>33FCF120-94EE-4877-98AE-0184413E1D4A</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Christopher</gtr:otherNames><gtr:surname>Coles</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802556"><gtr:id>9B0B75EC-2AE8-4543-B567-02EC0D9A4AF8</gtr:id><gtr:title>Use of bioenergetic profiling to generate biomarkers of stem cell potential.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802556</gtr:grantReference><gtr:abstractText>Stem cells have great potential for use in regenerative medicine and for basic research into mechanisms of human diseases. Two types of stem cell with particularly useful properties are human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC), both of which have the ability to renew themselves indefinitely and to become almost any type of specialized cell, which could be used to treat disease. The ability of hESC and iPSC cells to self-renew and maintain their special properties has traditionally been assessed using a set of stem cell genes and surface markers. However, testing for these markers is usually invasive and/or destructive and is only qualitatively related to the stem cell?s potential. We believe that such potential can be revealed by measuring the metabolism of stem cells; especially the way they generate energy to grow and develop. In our proposal we will compare the ?energy profile? of hESCs with that expressed by iPSC and non-stem cells to provide robust biomarkers of stem cell potential and viability. We have extensive experience of this kind of approach from working with early embryos, the source of embryonic stem cells. Specifically, we have shown that embryo metabolism can be linked to successful development and ultimately the capacity to give rise to a pregnancy. We expect to discover similar links between the metabolism, health and function of stem cells and believe that our project could play a key role in the translation of stem cell research from the laboratory to the clinic.</gtr:abstractText><gtr:technicalSummary>Human Embryonic Stem cells (hESC) have the ability to self-renew and to differentiate into a diverse range of specialized cells which may potentially be used in regenerative medicine and for basic research into disease mechanisms. Parallel opportunities are provided by the re-programming of somatic cells into pluripotent stem cells (so-called iPSC). Criteria for the successful establishment of embryonic stem cell potential have traditionally involved the expression of a panel of genes and surface antigens or the formation of teratomas in mice. However, the relationship of many of these markers to underlying cell biology is not clear, particularly when used as a ?snapshot? of the state of an entire culture,. By contrast, and drawing upon our research on early embryos, we hypothesise that stem cells can be characterised in terms of their metabolic phenotype and related cellular physiology. This proposition will be tested by comparing the metabolism, specifically the bioenergetics, of pluripotent cells (hESC lines, iPSC lines, human teratocarcinoma cells) and more differentiated cells at 3 levels of ?resolution? ? entire cell populations in culture, small colonies of cells and single cells ? and over time. Many of the metabolic/bioenergetic markers are non-invasive, allowing the data to be related to secondary analysis of cell biology and physiology. In this way, we aim to develop a range of novel markers of stem cell viability and potential. Our proposal will extend the boundaries of knowledge of stem cell biology beyond the genome and transcriptome-level by examining functional metabolic processes in real time.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>207739</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit (York)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>30863C19-2C63-4025-9FE8-4B7B7604BABD</gtr:id><gtr:impact>Ran a workship for approx 30 A-level Bilogy pupils on Reproductive Biotechnology and Stem cells.

Unknown impact as yet, however have been re-invited for 2013.</gtr:impact><gtr:outcomeId>ceqPrNZ6pAS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A method of assessing the viability of a cell wherein said cell is a gamete, an embryo, a karyoplast, a putative stem cell population, a stem cell precursor population or a stem cell population, said method comprising incubating the cell in a culture medium including a plurality of amino acids and determining the change in concentration in the medium of at least one amino acid.</gtr:description><gtr:grantRef>G0802556</gtr:grantRef><gtr:id>C89FF1C0-3CCA-4D40-B55D-ED4D5EA360EE</gtr:id><gtr:impact>Unknown as yet. Discussions are at an early stage with a UK Venture Capital company concerning these data.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>E3oWBaNWecm</gtr:outcomeId><gtr:patentId>US2010223681</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>A method of assessing the viability of a cell</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Basic Science Office for European Society of Human Reproduction and Embryology</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>3EA3319A-05AF-454E-BB77-2D4781764307</gtr:id><gtr:outcomeId>56e14ac00d4523.69263799</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Scientific Advisory Panel for Association of Clinical Embryologists</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4DE5B9A8-66C5-4383-8AA5-19805B22ECDB</gtr:id><gtr:impact>The UK ACE plays a vital role in defining and monitoring the standards of Clinical Embryologists as a health care profession in the UK, as well as informing best practice in the ART industry in the UK. Since working as a member of the UK ACE SAC, we have prepared official responses to inform the HFEA of a variety of issues, notably mitochondrial replacement therapy. In addition, a series of guideline updates have been prepared.</gtr:impact><gtr:outcomeId>56e14c0c89e3d4.47120451</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EEA9F16F-E5E6-40B3-9FC7-E5F74DEBA1FC</gtr:id><gtr:title>A simple approach for COnsumption and RElease (CORE) analysis of metabolic activity in single mammalian embryos.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03b75fb80e30a6f4e4766958592139c2"><gtr:id>03b75fb80e30a6f4e4766958592139c2</gtr:id><gtr:otherNames>Guerif F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54637be7a97fd4.80826174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B93A3F1-0BAC-4528-B69A-E11E090F2227</gtr:id><gtr:title>Metabolic heterogeneity during preimplantation development: the missing link?</gtr:title><gtr:parentPublicationTitle>Human reproduction update</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4786</gtr:issn><gtr:outcomeId>54637be7cf14f0.78715985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C9AC3F2-6DCB-429A-AB72-9546C93FA70F</gtr:id><gtr:title>Human cell dedifferentiation in mesenchymal condensates through controlled autophagy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5db94d6b70c7dc7ef3529bb60a4c52ac"><gtr:id>5db94d6b70c7dc7ef3529bb60a4c52ac</gtr:id><gtr:otherNames>Pennock R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56e045728f0ca3.29905251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0D11ADD-371E-42C9-A6C5-F4DC58A793D8</gtr:id><gtr:title>Elevated non-esterified fatty acid concentrations during bovine oocyte maturation compromise early embryo physiology.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58067b8961ba616fac6f523fbd98a19a"><gtr:id>58067b8961ba616fac6f523fbd98a19a</gtr:id><gtr:otherNames>Van Hoeck V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16332_22_21858021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10421C35-B3C6-4309-B76F-84DA4E682453</gtr:id><gtr:title>Human embryos from overweight and obese women display phenotypic and metabolic abnormalities.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ed54676a034a15ab4b49281c1767224"><gtr:id>6ed54676a034a15ab4b49281c1767224</gtr:id><gtr:otherNames>Leary C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>54647d64b2d7c8.99475181</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802556</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>